Florian Eichhorn

1.2k total citations
43 papers, 626 citations indexed

About

Florian Eichhorn is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Florian Eichhorn has authored 43 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 9 papers in Surgery. Recurrent topics in Florian Eichhorn's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Pleural and Pulmonary Diseases (8 papers). Florian Eichhorn is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Pleural and Pulmonary Diseases (8 papers). Florian Eichhorn collaborates with scholars based in Germany, United States and Austria. Florian Eichhorn's co-authors include Thomas Muley, H. Winter, Hans Hoffmann, Martin Eichhorn, Arne Warth, Hendrik Dienemann, Michael Thomas, Laura V. Klotz, Mark Kriegsmann and Helge Bischoff and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and British Journal of Cancer.

In The Last Decade

Florian Eichhorn

36 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Eichhorn Germany 16 334 327 154 79 68 43 626
Nicolás Moreno‐Mata Spain 15 150 0.4× 259 0.8× 87 0.6× 88 1.1× 71 1.0× 56 514
Veronica Tavaglione Italy 8 258 0.8× 99 0.3× 216 1.4× 67 0.8× 125 1.8× 8 460
Vito D’Alessandro Italy 12 212 0.6× 125 0.4× 173 1.1× 232 2.9× 31 0.5× 30 551
Deepti Singh India 8 240 0.7× 102 0.3× 203 1.3× 127 1.6× 49 0.7× 14 460
Toshiteru Nagashima Japan 16 179 0.5× 500 1.5× 57 0.4× 144 1.8× 193 2.8× 71 788
Paul N. Staats United States 20 199 0.6× 231 0.7× 137 0.9× 183 2.3× 194 2.9× 61 1.0k
Jorge D. Oldan United States 19 146 0.4× 267 0.8× 74 0.5× 117 1.5× 120 1.8× 71 871
Shin-ichi Yamashita Japan 15 149 0.4× 165 0.5× 42 0.3× 177 2.2× 108 1.6× 31 553
Paweł Gut Poland 14 225 0.7× 49 0.1× 261 1.7× 104 1.3× 73 1.1× 75 610

Countries citing papers authored by Florian Eichhorn

Since Specialization
Citations

This map shows the geographic impact of Florian Eichhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Eichhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Eichhorn more than expected).

Fields of papers citing papers by Florian Eichhorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Eichhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Eichhorn. The network helps show where Florian Eichhorn may publish in the future.

Co-authorship network of co-authors of Florian Eichhorn

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Eichhorn. A scholar is included among the top collaborators of Florian Eichhorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Eichhorn. Florian Eichhorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichhorn, Florian, Hans Hoffmann, Stefan Rieken, Felix Herth, & H. Winter. (2025). Trachealtumoren. Laryngo-Rhino-Otologie. 105(1). 13–24.
2.
Eichhorn, Florian, et al.. (2025). Robot‐Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort Study. Journal of Surgical Oncology. 131(8). 1543–1550.
3.
Kontogianni, Konstantina, António Bugalho, Felix Herth, et al.. (2025). Global Survey on Current Practices of Endobronchial Ultrasound Approaches to N2 Staging in Non-Small Cell Lung Cancer Following the Ninth Edition of the TNM Classification. Journal of Bronchology & Interventional Pulmonology. 33(1).
4.
Eichhorn, Florian, Claus Peter Heußel, Hans‐Ulrich Kauczor, et al.. (2025). Image analysis: 68Ga-FAPI-46 PET derived texture parameters improve the differentiation of malignant and benign pulmonary lesions. Cancer Imaging. 25(1). 73–73.
5.
Klotz, Laura V., Swaantje Casjens, Georg Johnen, et al.. (2024). Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients. Lung Cancer. 192. 107802–107802. 2 indexed citations
6.
Dittrich, Susanne, et al.. (2024). Lessons Learned. CHEST Journal. 167(4). 1012–1023. 1 indexed citations
7.
Klotz, Laura V., et al.. (2024). Gendermedizin bei Lungenerkrankungen. Die Chirurgie. 95(9). 730–735.
8.
Benesova, Karolina, Margarida Souto‐Carneiro, Florian Eichhorn, et al.. (2022). Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors. Frontiers in Oncology. 12. 1010660–1010660. 12 indexed citations
9.
Eichhorn, Martin, et al.. (2022). Thoracic surgery in the non-intubated spontaneously breathing patient. Respiratory Research. 23(1). 379–379. 13 indexed citations
10.
Klotz, Laura V., Hans Hoffmann, Rajiv Shah, et al.. (2022). Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach. Translational Lung Cancer Research. 11(11). 2230–2242. 15 indexed citations
11.
Eichhorn, Florian, Laura V. Klotz, Mark Kriegsmann, et al.. (2021). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung Cancer. 153. 150–157. 61 indexed citations
12.
Klotz, Laura V., Florian Eichhorn, Michael G. Thomas, et al.. (2021). Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center Experience. Respiration. 100(12). 1165–1173. 8 indexed citations
13.
Eichhorn, Florian & H. Winter. (2021). How to handle oligometastatic disease in nonsmall cell lung cancer. European Respiratory Review. 30(159). 200234–200234. 3 indexed citations
14.
Kriegsmann, Mark, Christiane Zgorzelski, Rita Casadonte, et al.. (2020). Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes. Cancers. 12(9). 2704–2704. 19 indexed citations
16.
Eichhorn, Florian, Alexander Harms, Arne Warth, et al.. (2018). PD-L1 expression in large cell neuroendocrine carcinoma of the lung. Lung Cancer. 118. 76–82. 30 indexed citations
17.
Kazdal, Daniel, Alexander Harms, Volker Endris, et al.. (2017). Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer. British Journal of Cancer. 117(2). 220–226. 25 indexed citations
18.
Rieber, Juliane, Julian Schmitt, Arne Warth, et al.. (2015). Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas. European journal of medical research. 20(1). 64–64. 31 indexed citations
19.
Eichhorn, Florian, Hendrik Dienemann, Thomas Muley, Arne Warth, & Hans Hoffmann. (2015). Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung. The Annals of Thoracic Surgery. 99(3). 983–989. 57 indexed citations
20.
Eichhorn, Florian, et al.. (2012). Luftnot, Husten und Tachykardie. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 107(4). 285–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026